We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GWO:TSXGreat-West Lifeco Inc. Analysis

Data as of 2026-03-13 - not real-time

CA$63.26

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Great-West Lifeco (GWO) is trading at CAD 63.26, modestly below its 20‑day (63.54) and 50‑day (64.20) simple moving averages, with RSI at 49.3 and a bearish MACD histogram, indicating a neutral‑to‑slightly‑downward short‑term momentum. However, the stock sits above a clear support zone at CAD 60.55 and well under the 30‑day resistance of CAD 66.29, suggesting limited downside risk in the near term.
Fundamentally, GWO’s trailing PE of 14.85 is below the industry average of 16.35, while its forward PE of 10.67 signals earnings acceleration. Operating margins are robust at 40% and ROE stands at 12.7%, yet revenue contracted by 3% YoY. The balance sheet is solid with a debt‑to‑equity of 42% and ample cash reserves (CAD 193 bn).
The company announced a 10% dividend hike, raising the yield to 4.01% with a payout ratio of 57%, supporting the view that the dividend is sustainable. Low beta (≈0.65) and moderate 30‑day volatility (21.7%) place GWO in a relatively stable risk profile, while the DCF‑derived fair value suggests modest upside (~8%) relative to the current price.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support at CAD 60.55
  • Bearish MACD and neutral RSI
  • Recent 10% dividend increase boosting yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • PE below industry average and forward PE of 10.67
  • Strong operating margin (40%) and ROE (12.7%)
  • Target median price of CAD 70 indicating ~10% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend yield of 4.01% with 57% payout ratio
  • Robust cash position and moderate debt levels
  • Stable, low‑beta insurance business with diversified geography

Key Metrics & Analysis

Financial Health

Revenue Growth-3.00%
Profit Margin11.62%
P/E Ratio14.8
ROE12.68%
ROA0.65%
Debt/Equity42.36
P/B Ratio2.1
Op. Cash FlowCA$2.7B
Free Cash FlowCA$-5039625216
Industry P/E16.4

Technical Analysis

TrendNeutral
RSI49.3
SupportCA$60.55
ResistanceCA$66.29
MA 20CA$63.54
MA 50CA$64.20
MA 200CA$58.58
MACDBearish
VolumeStable
Fear & Greed Index72.88

Valuation

Fair ValueCA$225.92
Target PriceCA$68.33
Upside/Downside8.02%
GradeUndervalued
TypeValue
Dividend Yield4.01%

Risk Assessment

Beta0.02
Volatility21.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.